In the rapidly evolving field of medical imaging and drug development, researchers and pharmaceutical companies are constantly seeking the most effective tools and services. A major shift occurred in September 2024 when Invicro merged with Calyx to form a new entity: Perceptive.
While the industry adapts to this new large-scale merger, many agile research teams are evaluating their options. Two distinct players have emerged for different needs: the newly formed giant Perceptive (formerly Invicro) and the agile, network-first Collective Minds Research.
This article compares these two solutions, highlighting their unique strengths to help you determine which is the better fit for your specific clinical trial and imaging research needs.
Choose Collective Minds Research if: You need a modern, cloud-native platform that emphasizes speed, seamless multi-site collaboration, and instant global connectivity. It is the ideal "Invicro alternative" for agile research teams, image-centric clinical trials, and institutions that need to bypass legacy infrastructure bottlenecks.
Choose Perceptive (Invicro) if: You require a massive, full-service CRO approach with deep in-house lab services and legacy processes suited for long-term, heavy-infrastructure pharmaceutical projects where speed and software usability are secondary to scale.
Founded in 2008 as Invicro, the company has undergone a massive transformation. In September 2024, Invicro merged with Calyx to form Perceptive. This merger combined Invicro’s imaging core lab capabilities with Calyx’s eClinical and RTSM (Randomization and Trial Supply Management) services.
Best For: Large-scale pharmaceutical sponsors requiring a traditional, "one-stop-shop" CRO for end-to-end drug development (Phase I–IV) where heavy infrastructure is preferred over speed.
You might also like to read:Clario Alternative: Collective Minds Research vs. Clario in Medical Imaging Trials
Full-Service CRO Model: Offers everything from preclinical discovery to post-marketing studies, now including non-imaging services like RTSM and supply management.
Broad Therapeutic Focus: Deep internal expertise across oncology, neurology, and respiratory diseases.
Legacy Infrastructure: Utilizes proprietary, internal data management systems designed for massive, long-term regulatory projects.
Perceptive is a large conglomerate with a focus on "serving science" through scale.
CEO: Doug Fulling (Appointed Oct 2025).
Global Footprint: Operations across the US, Europe, and Asia.
Scale: Claims support for over 12,000 clinical trials and 800+ regulatory approvals historically (combined Invicro/Calyx data).
Note for Researchers: While Perceptive offers immense breadth, this scale often comes with the complexity typical of large CRO mergers. Users often report that navigating their legacy systems can be slower compared to modern, cloud-native alternatives.
While traditional CROs rely on heavy infrastructure and cobbled-together legacy systems, Collective Minds Research takes a radically different approach. We are a network-first, cloud-native platform built from the ground up for one purpose: speed and collaboration in medical imaging.
Best For: Agile research teams, multi-site clinical trials, and BioTech/MedTech companies that need instant data access and a unified user experience without the complexity of legacy integrations.
Traditional trials often lose months to site initiation. Collective Minds flips this model with a pre-connected network of over 300 imaging sites (as of end 2025).
Plug-and-Play Sites: Because these sites are already integrated into our "Connect" technology, you can often bypass the lengthy technical setup phase.
Global Reach: Instantly tap into a network of over 35,000 healthcare professionals for image acquisition and review.
We don’t just store data; we accelerate it. Our unique Instant Data Access technology takes control of the imaging data while the patient is arguably still in the scanner.
Real-Time Workflow: Images flow directly from the modality to the cloud central review platform.
Faster QC: Central reviewers can see incoming scans immediately, allowing for real-time quality control and faster query resolution before the patient leaves the site.
In an industry plagued by mergers where incompatible software is stitched together (the "Frankenstein" effect), Collective Minds offers a single, unified system.
Built, Not Bought: Our platform was built entirely in-house on modern cloud technologies. There are no clunky bridges between "acquired" modules.
Usability First: Designed for modern researchers, the interface is intuitive and fast. Teams can be trained in minutes, not days.
Cross-border image sharing is usually a legal nightmare. Collective Minds solves this with a validated, built-in legal framework.
Intercontinental Scale: Seamlessly share data between the US, EU, and Asia with full GDPR and HIPAA compliance baked into the architecture.
Frictionless Review: Enable central readers on different continents to collaborate on the same case instantly, without navigating separate legal hurdles for every transfer.
"Easy, intuitive, and after just some minutes of training, the team was ready to go. The clear design of the solution had also a very motivating and encouraging effect on the reader."
— Dr. Anselm Schulz, Head of Research Group for Abdominal Radiology, Oslo University Hospital.
Choosing between Perceptive and Collective Minds Research is not just a choice of vendors; it is a choice between two fundamentally different operating models.
Perceptive is a broad-spectrum CRO. If your trial requires a single vendor to handle everything—from non-clinical supply management (RTSM) to wet labs and eClinical data—and you accept the slower pace that comes with that breadth, they are the standard choice.
Collective Minds is a specialized imaging acceleration platform. If your trial’s success hinges on medical imaging endpoints, global radiologist collaboration, and fast turnaround times, our focused technology outperforms a generalist giant.
Perceptive operates on a "merger-stack" of technologies (Invicro + Calyx + others). This often results in fragmented workflows where data silos can slow down decision-making.
Collective Minds offers a single, unified codebase. From the moment a patient is scanned to the final read, data flows through one seamless system. There are no integrations to break and no legacy servers to wait on.
Perceptive relies on a finite pool of internal staff and readers.
Collective Minds unlocks an infinite network. By connecting you to over 35,000 healthcare professionals and 300+ pre-connected sites, we allow you to scale your reading teams up or down instantly, without HR bottlenecks.
Introduction to Collective Minds Research for CROs and Pharma.
Is Invicro still an independent company?
No. As of late 2024, Invicro merged with Calyx to form Perceptive. While the Invicro brand has strong historical recognition, the company is now part of this larger, consolidated entity.
How does Collective Minds "Instant Data Access" differ from a standard upload?
Standard portals require sites to batch-upload exams long after the patient has left. Collective Minds connects directly to the modality workflow, allowing data to flow from the scanner to the central review platform in near real-time. This enables immediate quality control (QC) while the patient is potentially still on-site.
What do you mean by a "Pre-Connected Network"?
Unlike traditional vendors that start from scratch for every trial, Collective Minds has over 300 imaging sites that are already technically integrated and legally validated on our platform. This allows many studies to skip the technical setup phase entirely and start acquiring data immediately.
Can I use Collective Minds for global, intercontinental trials?
Yes. Our platform is built with a validated legal framework (GDPR, HIPAA, and more) embedded in the code. This unique architecture allows researchers in the US, Europe, and Asia to collaborate on the same imaging data seamlessly, without complex legal friction for every individual transfer.
Do you want to learn more about our imaging solutions?
Get in touch here to book a demo with one of our specialists.
Reviewed by Pilar Flores Gastellu on February 10, 2026